Published in Arch Dermatol on December 01, 1988
Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 5.43
The role of vitamin D in cancer prevention. Am J Public Health (2005) 4.99
Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr (2007) 3.89
Not enough vitamin D: health consequences for Canadians. Can Fam Physician (2007) 2.03
Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol (2013) 1.41
Does vitamin D make the world go 'round'? Breastfeed Med (2008) 1.35
Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older. Osteoporos Int (2006) 1.24
Solar UV doses of adult Americans and vitamin D(3) production. Dermatoendocrinol (2011) 1.23
Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European country. BMC Public Health (2009) 1.19
The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients (2010) 1.18
Low vitamin D status: definition, prevalence, consequences, and correction. Endocrinol Metab Clin North Am (2010) 1.18
Evidence-based D-bate on health benefits of vitamin D revisited. Dermatoendocrinol (2012) 1.12
Vitamin D-insufficiency: An estimate of the situation in Germany. Dermatoendocrinol (2012) 0.99
Vitamin D concentrations in Asian children living in England. Limited vitamin D intake and use of sunscreens may lead to rickets. BMJ (1999) 0.95
Vitamin D status during pregnancy and aspects of offspring health. Nutrients (2010) 0.95
Brazilian consensus on photoprotection. An Bras Dermatol (2015) 0.94
Is there an epidemic vitamin D deficiency in German orthopaedic patients? Clin Orthop Relat Res (2013) 0.87
Solar UV doses of young Americans and vitamin D3 production. Environ Health Perspect (2011) 0.86
Could sunscreens increase melanoma risk? Am J Public Health (1992) 0.84
The role of vitamin D in pregnancy and lactation: emerging concepts. Womens Health (Lond Engl) (2012) 0.84
Exponentially increasing incidences of cutaneous malignant melanoma in Europe correlate with low personal annual UV doses and suggests 2 major risk factors. Dermatoendocrinol (2015) 0.77
Are hip fractures preventable with nutritional measures and exercise in the elderly? Osteoporos Int (1996) 0.77
Low serum vitamin D-status, air pollution and obesity: A dangerous liaison. Rev Endocr Metab Disord (2017) 0.76
Vitamin D status and the prevalence of deficiency in lactating women from eight provinces and municipalities in China. PLoS One (2017) 0.75
Profile of Vitamin D in patients attending at general hospital Mahad India. Indian J Endocrinol Metab (2017) 0.75
Photodamaged skin. Update on therapeutic management. Can Fam Physician (1993) 0.75
Systemic lupus erythematosus and fractures. RMD Open (2015) 0.75
Worldwide cutaneous malignant melanoma incidences analyzed by sex, age, and skin type over time (1955-2007): Is HPV infection of androgenic hair follicular melanocytes a risk factor for developing melanoma exclusively in people of European-ancestry? Dermatoendocrinol (2016) 0.75
Cutaneous malignant melanoma incidences analyzed worldwide by sex, age, and skin type over personal Ultraviolet-B dose shows no role for sunburn but implies one for Vitamin D3. Dermatoendocrinol (2016) 0.75
Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr (2000) 11.69
Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab (1988) 7.09
Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet (1982) 6.40
Epidemic influenza and vitamin D. Epidemiol Infect (2006) 5.32
Redefining vitamin D insufficiency. Lancet (1998) 5.26
Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest (1985) 3.59
Neuroendocrinology of the skin. Endocr Rev (2000) 3.34
Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab (1983) 3.27
An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int (1999) 3.07
Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science (1980) 3.06
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Ultraviolet B and blood pressure. Lancet (1998) 2.83
Control of 25-hydroxycholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci U S A (1972) 2.77
1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science (1972) 2.50
Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry (1971) 2.50
Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab (1987) 2.35
Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol (1991) 2.33
A possible genetic defect in 25-hydroxylation as a cause of rickets. J Pediatr (1994) 2.22
Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science (1981) 2.20
A new chromatographic system for vitamin D3 and its metabolites: resoluation of a new vitamin D3 metabolite. J Lipid Res (1971) 2.12
Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int (1998) 2.07
Hypervitaminosis D associated with drinking milk. N Engl J Med (1992) 1.90
Age, vitamin D, and solar ultraviolet. Lancet (1989) 1.82
Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science (1982) 1.80
Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine. Proc Natl Acad Sci U S A (1971) 1.78
Methods for the determination of the circulating concentration of 25-hydroxyvitamin D. J Nutr Biochem (1990) 1.76
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J (2001) 1.74
The effect of standard- and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. JAMA (1991) 1.74
Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev (1998) 1.69
21,25-dihydroxycholecalciferol. A metabolite of vitamin D3 preferentially active on bone. Biochemistry (1970) 1.65
An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr (1990) 1.65
The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. Endocrinology (1972) 1.63
Race/ethnic differences in bone mineral density in men. Osteoporos Int (2007) 1.63
Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney. Biochemistry (1972) 1.62
25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet (2001) 1.61
Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med (1993) 1.58
1 alpha,25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest (1984) 1.52
Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med (2001) 1.51
Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med (1973) 1.50
Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxyvitamin D3 in thyroparathyroidectomized rats. Endocrinology (1974) 1.48
Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States) Cancer Causes Control (1998) 1.46
Effect of vitamin D supplementation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: a randomized, crossover clinical trial. Br J Dermatol (2013) 1.46
1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone. Endocrinology (1981) 1.40
25,26-dihydroxycholecalciferol, a metabolite of vitamin D3 with intestinal calcium transport activity. Biochemistry (1970) 1.40
Glycosaminoglycans in histologic sections. Arch Dermatol (1987) 1.39
High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int (2006) 1.39
CRH functions as a growth factor/cytokine in the skin. J Cell Physiol (2006) 1.38
Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol (1986) 1.35
Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab (1997) 1.34
Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med (1981) 1.33
Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med (1975) 1.33
The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol (1981) 1.32
Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr (1985) 1.30
Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab (1985) 1.30
Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. J Clin Invest (1995) 1.30
Photometabolism of 7-dehydrocholesterol to previtamin D3 in skin. Biochem Biophys Res Commun (1977) 1.30
Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. N Engl J Med (1982) 1.29
Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables. Fed Proc (1987) 1.29
Vitamin D and cancer. Anticancer Res (2006) 1.28
1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance. Pediatr Res (1975) 1.28
Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res (1986) 1.27
1,25-dihydroxycholecalciferol: metabolite of vitamin D3 active on bone in anephric rats. Science (1972) 1.26
Indian and Pakistani immigrants have the same capacity as Caucasians to produce vitamin D in response to ultraviolet irradiation. Am J Clin Nutr (1986) 1.25
Effect of I,25-dihydroxycholecalciferol in renal osteodystrophy. Can Med Assoc J (1975) 1.24
An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J Steroid Biochem Mol Biol (2007) 1.24
Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J Clin Endocrinol Metab (1989) 1.21
The physiologic significance of plasma transport of vitamin D and metabolites. Am J Med (1974) 1.20
Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest (1993) 1.20
Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab (1992) 1.20
Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci (1999) 1.18
Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cells. FEBS Lett (1999) 1.17
Active steroidogenesis in the normal rat skin. Biochim Biophys Acta (2000) 1.17
1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine. J Biol Chem (1973) 1.17
Mechanism of action of 1,25-dihydroxycholecalciferol on intestinal calcium transport. Proc Natl Acad Sci U S A (1971) 1.15
A method for the determination of the circulating concentration of 1,25-dihydroxyvitamin D. J Nutr Biochem (1990) 1.14
The role of sunlight in the cutaneous production of vitamin D3. Annu Rev Nutr (1988) 1.13
Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial. J Clin Endocrinol Metab (1998) 1.13
A characterization of hypothalamic-pituitary-adrenal axis function during and after human cardiac arrest. Crit Care Med (1993) 1.12
The photobiogenesis and metabolism of vitamin D. Fed Proc (1978) 1.10
Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol (2001) 1.10
A parathyroid hormone inhibitor in vivo: design and biological evaluation of a hormone analog. Science (1983) 1.10
1 -Hydroxy derivative of vitamin D 3 : a highly potent analog of 1 ,25-dihydroxyvitamin D 3 . Science (1973) 1.10
Relationship of 25-hydroxyvitamin D3 side chain structure to biological activity. J Biol Chem (1975) 1.08
Selective vitamin D receptor modulators and their effects on colorectal tumor growth. J Steroid Biochem Mol Biol (2007) 1.08
A method for the determination of the circulating concentration of vitamin D. J Nutr Biochem (1990) 1.08
Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease. Inflamm Bowel Dis (2011) 1.07
Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim (2001) 1.07
The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density. J Bone Miner Res (1997) 1.07
Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin. J Biol Chem (1993) 1.07
Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab (1998) 1.06
Premature graying of hair is a risk marker for osteopenia. J Clin Endocrinol Metab (1994) 1.06
Interaction of 1,25-dihydroxyvitamin-D3 with keratinocytes and fibroblasts from skin of normal subjects and a subject with vitamin-D-dependent rickets, type II: a model for study of the mode of action of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab (1983) 1.05
Silica Sep-Pak preparative chromatography for vitamin D and its metabolites. J Chromatogr (1981) 1.05
What's the use of generating melanin? Exp Dermatol (1999) 1.04